ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.0090
-0.0004 (-4.26%)
At close: Oct 21, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $163.08 thousand as of October 22, 2026. It is the 50,988th most valuable company in the world and the 7,167th biggest in the United States. Its market cap has decreased by 99.26% in one year.
Market Cap
163.08K
Enterprise Value
9.26M
Revenue
3.85M
Global Rank
Country Rank
#7,167 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 163.08K, a decrease of -96.77%. That is a compound annual growth rate of -10.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 163.08K | -92.11% |
| Dec 31, 2025 | 2.07M | -88.57% |
| Dec 31, 2024 | 18.08M | -77.84% |
| Dec 29, 2023 | 81.56M | -47.97% |
| Dec 30, 2022 | 156.75M | 41.18% |
| Dec 31, 2021 | 111.03M | 4.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stella Diagnostics | 3.02M |
| iMD Companies | 2.33M |
| IDenta | 1.53M |
| InVitro International | 1.34M |
| Hypha Labs | 737.53K |
| NovelStem International | 325.59K |
| Medical Imaging | 63.82K |
| T2 Biosystems | 22.44K |